Canada Cancer Research
Top 5 Globally in Precision Medicine & AI Innovation
Stem Cell Expansion
UM171 breakthrough
Global Cancer Research Rank
Princess Margaret #1 in Canada
Faster Drug Discovery
AI-powered design
UM171 Revolutionary Cell Therapy Discovery
Canadian scientists discovered UM171, a small molecule that expands blood stem cells by 35-fold, revolutionizing bone marrow transplants and CAR-T therapy production.
Impact:
Making stem cell transplants possible for patients without perfect donor matches
AI-Powered Drug Design Platform
Canadian researchers developed AI systems that design new cancer drugs in weeks instead of years, identifying compounds that big pharma missed.
Impact:
Accelerating cancer drug discovery by 10x
Actinium-225 Radioisotope Therapy
Canada leads production of Actinium-225, a powerful radioactive isotope used in targeted alpha therapy for metastatic cancers resistant to other treatments.
Impact:
Destroying cancer cells with minimal damage to healthy tissue
First-in-Human Oncolytic Virus Trials
Canadian biotech companies pioneered using engineered viruses that selectively infect and kill cancer cells while sparing normal tissue.
Impact:
Harnessing viruses to fight cancer
Liquid Biopsy for Early Detection
Canadian researchers developed blood tests that detect cancer DNA fragments months before tumors appear on imaging, enabling ultra-early intervention.
Impact:
Catching cancer at its most curable stage
Universal Healthcare Cancer Outcomes Research
Canada's single-payer system provides unique population-level data on cancer treatment effectiveness, informing global best practices.
Impact:
Proving which treatments actually work in real-world populations
Princess Margaret Cancer Centre
Toronto, Ontario
One of the world's top 5 cancer research centers. Leading AI drug discovery, liquid biopsy, and proton therapy. Affiliated with University of Toronto.
Key Specialties:
BC Cancer
Vancouver, British Columbia
Western Canada's leading cancer center. Pioneer in personalized oncology, genomic medicine, and population cancer research.
Key Specialties:
Institut de Recherche en Immunologie et en Cancérologie (IRIC)
Montreal, Quebec
World-renowned for UM171 discovery. Leading research in cancer immunology and cellular therapy innovation.
Key Specialties:
Canada welcomes international patients to cutting-edge clinical trials
UM171 Enhanced CAR-T Therapy
Using UM171 to create more powerful CAR-T cells that persist longer and work against solid tumors.
Actinium-225 Targeted Alpha Therapy
Testing Actinium-225 radioisotope therapy for metastatic prostate, neuroendocrine, and other cancers resistant to standard treatments.
AI-Designed Cancer Drug (First-in-Human)
First human trial of a cancer drug designed entirely by artificial intelligence for specific genetic mutations.
Liquid Biopsy Early Detection Program
Nationwide study using liquid biopsies to detect cancer recurrence early in high-risk patients.
Registry-listed trials for Canada currently tracked in our database, sourced from public trial registries.
